Wiltzius, Jed,Alvarez Rodriguez, Ruben,Belk, Jonathan
申请号：
AU2017240150
公开号：
AU2017240150A2
申请日:
2017.03.31
申请国别(地区):
AU
年份:
2019
代理人:
摘要：
The invention provides antibodies, antigen binding fragments thereof, chimeric antigen receptors (CARs), and engineered T cell receptors, polynucleotides encoding the same, and in vitro cells comprising the same. The polynucleotides, polypeptides, and in vitro cells described herein can be used in an engineered CAR T cell therapy for the treatment of a patient suffering from a cancer. In one embodiment, the polynucleotides, polypeptides, and in vitro cells described herein can be used for the treatment of multiple myeloma.
